Literature DB >> 1588563

Novel thiazolidine-2,4-diones as potent euglycemic agents.

B Hulin1, D A Clark, S W Goldstein, R E McDermott, P J Dambek, W H Kappeler, C H Lamphere, D M Lewis, J P Rizzi.   

Abstract

A new series of thiazolidine-2,4-diones was obtained by replacing the ether function of englitazone with various functional groups, i.e., a ketone, alcohol, or olefin moiety. These compounds lower blood glucose levels in the genetically obese and insulin-resistant ob/ob mouse. Appending an oxazole-based group at the terminus of the chain provided highly potent compounds.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1588563     DOI: 10.1021/jm00088a022

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  Oral bioavailability and pharmacokinetics of PAT-5A, a new insulin sensitizer in rats.

Authors:  Rao N V S Mamidi; Kasiram Katneni; Ramesh Mullangi; Rajagopalan Ramanujam
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Jul-Sep       Impact factor: 2.441

Review 2.  Thiazolidinediones: An In-Depth Study of Their Synthesis and Application to Medicinal Chemistry in the Treatment of Diabetes Mellitus.

Authors:  Nathan Long; Adam Le Gresley; Stephen P Wren
Journal:  ChemMedChem       Date:  2021-05-04       Impact factor: 3.466

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.